Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic.

Ipek Eren Vural Matthew Herder Agnieszka Doll Janice E Graham

Published in: International journal of health policy and management (2023)

Beyond incremental change in policy goals, such as public investment in domestic biomanufacturing, the features of Canadian public policies endorsing financialization in the biopharmaceutical sector remained largely unchanged during the pandemic.

Keyphrases

healthcare
mental health
public health
sars cov
coronavirus disease
adverse drug
emergency department
electronic health record